Loading
Latest filing published 06 May 2026 for Jiangsu Recbio Technology Co., Ltd. - B.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Wang Jing across 5 companies, led by China Sinostar Group Co. Ltd., Singularity Future Technology Ltd. and CanSino Biologics Inc. Between 20 September 2017 and 29 April 2026, the trades on record add up to 12 filings.
In open-market terms, that means 3 purchases on one side and 4 sales worth €272k on the other. The totals do not cover 6 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants. 2026 to date brings 1 purchase and 1 sale.
The newest entry dates from 6 May 2026: an open-market sale, in Jiangsu Recbio Technology Co., Ltd. - B. The last purchase on record was published on 30 March 2026, which is 209 days ago. The median gap between a trade and its publication by SEC (Form 4) is 6 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations